Ignite Creation Date:
2025-12-24 @ 11:34 PM
Ignite Modification Date:
2026-05-18 @ 1:50 PM
Study NCT ID:
NCT02696356
Status:
COMPLETED
Last Update Posted:
2018-06-14
First Post:
2016-02-03
Is Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
Phase 1 Study of GRN-1201 in HLA-A*02 Subjects With Resected Melanoma
Sponsor:
BrightPath Biotherapeutics
Organization: